Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia
· Delayed Price · Currency is AUD 0.250
-0.005 (-1.96%)
At close: Mar 9, 2026
ASX:PAR Revenue
Paradigm Biopharmaceuticals had revenue of 25.15K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 8.45K, down -49.40% year-over-year.
Revenue (ttm)
8.45K
Revenue Growth
-49.40%
P/S Ratio
12,995.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
109.81M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Island Pharmaceuticals | 62.85K |
| Botanix Pharmaceuticals | 21.92M |
| Recce Pharmaceuticals | 974.56K |
| Arovella Therapeutics | 3.21M |
| Actinogen Medical | 7.36M |
| LTR Pharma | 1.13M |
| Cynata Therapeutics | 1.69M |
| Alterity Therapeutics | 6.64M |